Skip to main content

Peer Review reports

From: Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study

Original Submission
4 Mar 2020 Submitted Original manuscript
20 Apr 2020 Reviewed Reviewer Report - Hui-Chuan Sun
9 Jun 2020 Reviewed Reviewer Report
27 Jun 2020 Author responded Author comments - Di Ma
Resubmission - Version 2
27 Jun 2020 Submitted Manuscript version 2
9 Jul 2020 Reviewed Reviewer Report
2 Sep 2020 Reviewed Reviewer Report - Research Square Reviewer 1
10 Sep 2020 Author responded Author comments - Di Ma
Resubmission - Version 3
10 Sep 2020 Submitted Manuscript version 3
17 Sep 2020 Author responded Author comments - Di Ma
Resubmission - Version 4
17 Sep 2020 Submitted Manuscript version 4
Publishing
21 Sep 2020 Editorially accepted
29 Sep 2020 Article published 10.1186/s12885-020-07447-3

You can find further information about peer review here.

Back to article page